Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677751

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1677751

Electronic Skin Market Growth, Size, Trends Analysis - By Product Type, By Component, By Sensors, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

PUBLISHED:
PAGES: 251 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Electronic Skin Market Introduction and Overview

According to SPER market research, 'Global Electronic Skin Market Size- By Product Type, By Component, By Sensors, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Electronic Skin Market is predicted to reach 89.65 billion by 2034 with a CAGR of 23.21%.

Electronic skin, or e-skin, is a very thin electronic material made by combining electronic devices with flexible, stretchable materials. This new technology is mainly designed for health monitoring and medical uses, such as sensing vital signs within the body. E-skin is also making its mark in consumer electronics and robotics. In consumer markets, it may replace current wearable devices, creating a new interface for controlling electronics. In robotics, e-skin can enhance the sense of touch.

Restraints: The potential for the electronic skin patch to transform healthcare is enormous. However, privacy and data security issues present a major barrier to broad adoption. Because these patches gather private health information, strong security protocols are essential for gaining user confidence and expanding the industry. A variety of personal health data, such as blood sugar levels, heart rate, and even brain activity, are collected by electric skin patches. Personal health information can be gleaned from this data.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product Type, By Component, By Sensors, By Application.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered MC10, Xsensio, Rotex Inc, Renew Health Limited (Intelesens ltd.), Xenoma Inc, VivaLnK, Inc, Chrono Therapeutics, iRhythm, Holst Centre, Byteflies & Quad Industries, Bloomlife, Dexcom, Insulet Corporation, Feeligreen, Gentag. and others.

Electronic Skin Market Segmentation:

By Product Type: Based on the Product Type, Global Electronic Skin Market is segmented as; Electronic Patches, Electronic Skin Suits.

By Component: Based on the Component, Global Electronic Skin Market is segmented as; Stretchable Circuits, Photovoltaics Systems, Stretchable Conductors, Electroactive Polymers.

By Sensors: Based on the Sensors, Global Electronic Skin Market is segmented as; Tactile Sensors, Chemical Sensors, Electrophysiological Sensors, Others.

By Application: Based on the Application, Global Electronic Skin Market is segmented as; Health Monitoring Systems, Drug Delivery Systems, Cosmetics.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA2560

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Electronic Skin Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Electronic Skin Market

7. Global Electronic Skin Market, By Product Type (USD Million) 2021-2034

  • 7.1. Electronic Patches
  • 7.2. Electronic Skin Suits

8. Global Electronic Skin Market, By Component (USD Million) 2021-2034

  • 8.1. Stretchable Circuits
  • 8.2. Photovoltaics Systems
  • 8.3. Stretchable Conductors
  • 8.4. Electroactive Polymers

9. Global Electronic Skin Market, By Sensors (USD Million) 2021-2034

  • 9.1. Tactile Sensors
  • 9.2. Chemical Sensors
  • 9.3. Electrophysiological Sensors
  • 9.4. Others

10. Global Electronic Skin Market, By Application (USD Million) 2021-2034

  • 10.1. Health Monitoring Systems
  • 10.2. Drug Delivery Systems
  • 10.3. Cosmetics

11. Global Electronic Skin Market, (USD Million) 2021-2034

  • 11.1. Global Electronic Skin Market Size and Market Share

12. Global Electronic Skin Market, By Region, (USD Million) 2021-2034

  • 12.1. Asia-Pacific
    • 12.1.1. Australia
    • 12.1.2. China
    • 12.1.3. India
    • 12.1.4. Japan
    • 12.1.5. South Korea
    • 12.1.6. Rest of Asia-Pacific
  • 12.2. Europe
    • 12.2.1. France
    • 12.2.2. Germany
    • 12.2.3. Italy
    • 12.2.4. Spain
    • 12.2.5. United Kingdom
    • 12.2.6. Rest of Europe
  • 12.3. Middle East and Africa
    • 12.3.1. Kingdom of Saudi Arabia
    • 12.3.2. United Arab Emirates
    • 12.3.3. Qatar
    • 12.3.4. South Africa
    • 12.3.5. Egypt
    • 12.3.6. Morocco
    • 12.3.7. Nigeria
    • 12.3.8. Rest of Middle-East and Africa
  • 12.4. North America
    • 12.4.1. Canada
    • 12.4.2. Mexico
    • 12.4.3. United States
  • 12.5. Latin America
    • 12.5.1. Argentina
    • 12.5.2. Brazil
    • 12.5.3. Rest of Latin America

13. Company Profile

  • 13.1. MC10
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Xsensio
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Rotex Inc
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Renew Health Limited (Intelesens ltd.)
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Xenoma Inc
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. VivaLnK, Inc
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Chrono Therapeutics
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. iRhythm
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. Holst Centre
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Byteflies & Quad Industries
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Bloomlife
    • 13.11.1. Company details
    • 13.11.2. Financial outlook
    • 13.11.3. Product summary
    • 13.11.4. Recent developments
  • 13.12. Dexcom
    • 13.12.1. Company details
    • 13.12.2. Financial outlook
    • 13.12.3. Product summary
    • 13.12.4. Recent developments
  • 13.13. Insulet Corporation
    • 13.13.1. Company details
    • 13.13.2. Financial outlook
    • 13.13.3. Product summary
    • 13.13.4. Recent developments
  • 13.14. Feeligreen
    • 13.14.1. Company details
    • 13.14.2. Financial outlook
    • 13.14.3. Product summary
    • 13.14.4. Recent developments
  • 13.15. Gentag
    • 13.15.1. Company details
    • 13.15.2. Financial outlook
    • 13.15.3. Product summary
    • 13.15.4. Recent developments
  • 13.16. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!